statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	866
SG - Singapore	150
BR - Brasile	97
CN - Cina	94
HK - Hong Kong	92
IT - Italia	89
SE - Svezia	68
DE - Germania	58
BG - Bulgaria	32
VN - Vietnam	26
GB - Regno Unito	19
CI - Costa d'Avorio	15
CA - Canada	14
FR - Francia	13
RU - Federazione Russa	11
IN - India	10
FI - Finlandia	9
TR - Turchia	8
GR - Grecia	7
BE - Belgio	6
ID - Indonesia	6
UA - Ucraina	5
AR - Argentina	4
CH - Svizzera	4
ES - Italia	4
JP - Giappone	4
NL - Olanda	4
BD - Bangladesh	3
KE - Kenya	3
MY - Malesia	3
PL - Polonia	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
CZ - Repubblica Ceca	2
EG - Egitto	2
IL - Israele	2
LV - Lettonia	2
PH - Filippine	2
PY - Paraguay	2
SN - Senegal	2
AE - Emirati Arabi Uniti	1
BA - Bosnia-Erzegovina	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
EC - Ecuador	1
ET - Etiopia	1
HN - Honduras	1
IQ - Iraq	1
IS - Islanda	1
JO - Giordania	1
KR - Corea	1
KZ - Kazakistan	1
LB - Libano	1
LT - Lituania	1
MX - Messico	1
NG - Nigeria	1
NP - Nepal	1
OM - Oman	1
PK - Pakistan	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
VE - Venezuela	1
ZA - Sudafrica	1
Totale	1.771

Nome	#
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole	204
Sexual dysfunctions and suicidality in patients with bipolar disorder and unipolar depression.	192
The role of platelet/lymphocyte serotonin transporter in depression and beyond.	191
The neurobiology of moral sense: facts or hypotheses?	180
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma	178
A survey on virtual environment applications to fear of public speaking	167
Insight in Psychiatry and Neurology: State of the Art, and Hypotheses	144
Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis	143
Social cognition in people with schizophrenia: A cluster-analytic approach	123
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia	114
Metabolic syndrome and major depression.	90
null	64
Totale	1.790

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	11	0	0	0	0	0	0	0	0	0	0	0	11
2021/2022	123	1	5	1	7	32	13	1	10	11	1	11	30
2022/2023	195	23	35	13	9	25	21	5	11	41	0	11	1
2023/2024	111	9	16	16	4	13	21	4	11	4	1	2	10
2024/2025	438	2	12	13	32	63	52	37	20	48	60	39	60
2025/2026	395	47	38	44	38	57	46	42	15	17	38	11	2
Totale													1.790

CINECA IRIS Institutional Research Information System